| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212396C Method for raising activity of streptoverticillium to produce trans glutaminase |
| 07/27/2005 | CN1212395C Mutation alpha-amylase |
| 07/27/2005 | CN1212394C Glutathione peroxidase and method of manufacturing thereof |
| 07/27/2005 | CN1212393C Gene engineering strain M1033WZ expression M1033GI mutation enzyme GIG138P and construction method thereof |
| 07/27/2005 | CN1212388C Polyvinylalcophol degradative enzyme high productive bacteria and method of its seed selection and using said bacteria to produce polyving/alcohol/degradation enzyme by fermentation method |
| 07/27/2005 | CN1212386C Process for preparing pectinase by solid fermentation of coom aspergillus mutant K58 |
| 07/27/2005 | CN1212072C Activation of hydrolase for proteins in seeds of oil crops and hydrolysis for vegetable protein |
| 07/27/2005 | CA2525582A1 Synthetic nucleic acids from aquatic species |
| 07/26/2005 | US6921849 Dwarfism genes and dwarf plants |
| 07/26/2005 | US6921847 Lipoxygenase polynucleotides and methods of use |
| 07/26/2005 | US6921815 Controlling gene expression; plants |
| 07/26/2005 | US6921813 Comprises subunit of RNA polymerase holoenzyme which confers promoter sequence recognition and initiation of transcription for designing drugs to prevent mycobacterium infections; gene expression inhibition |
| 07/26/2005 | US6921665 Generation of differentiaed cells; obtain stem cells, transform with vector coding preferential proteins and reporter molecules, deplete undifferentiated stem cells from culture pool, recover differentiated cells |
| 07/26/2005 | US6921664 Telomerase |
| 07/26/2005 | US6921659 Gram-negative bacterial cell deficient hydrolase/protease activity for use in generating uncleaved heterologously expressed polypeptides; somatotropins |
| 07/26/2005 | US6921658 Serine protease BSSP6 |
| 07/26/2005 | US6921657 Protease variants and compositions |
| 07/26/2005 | US6921656 Comprises heat resistant hydrolase for production of glucose, isomerized sugars, oligosaccharides, liquors and fermented alchol |
| 07/26/2005 | US6921655 Endoglucanases and cellulase preparations containing the same |
| 07/26/2005 | US6921654 Comprises peptide complex for diagnosing and treating inflammation, cancer, arteriosclerosis and psoriasis |
| 07/26/2005 | US6921653 Crystalline UDP-glycosyl transferase (MurG) and methods of use thereof |
| 07/26/2005 | US6921652 Hydrolysis of an oil or fat by mixing and feeding an oil-phase substrate and a water-phase substrate to a packed layer; obtain substrate, expose to packed layer, incubate with lipase, monitor hydrolytic reaction |
| 07/26/2005 | US6921651 Process for the preparation of amino acids by using coryneform bacteria with attenuated 1-phosphofructokinase activity |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | US6921641 Thermostable UvrA and UvrB polypeptides and methods of use |
| 07/26/2005 | US6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 07/26/2005 | CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/21/2005 | WO2005066362A2 Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies |
| 07/21/2005 | WO2005066351A2 Enzymatic treatment of oils |
| 07/21/2005 | WO2005066347A1 Proteins |
| 07/21/2005 | WO2005066341A1 A method for the preparation of cross linked protein crystals |
| 07/21/2005 | WO2005066339A2 Polypeptides of alicyclobacillus sp. |
| 07/21/2005 | WO2005066337A2 Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation |
| 07/21/2005 | WO2005066336A1 Process for production of large amount of penicillin v acylase |
| 07/21/2005 | WO2005066335A1 Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain |
| 07/21/2005 | WO2005066334A1 Phosphokinase and the usage thereof |
| 07/21/2005 | WO2005065418A2 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 07/21/2005 | WO2005065384A2 Electronic trading data integration and protection system |
| 07/21/2005 | WO2005065239A2 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | WO2005065019A2 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 07/21/2005 | WO2005047473A3 Single vector dual gene therapy for pulmonary hypertension |
| 07/21/2005 | WO2005040370A3 Thermostable hydrolase |
| 07/21/2005 | WO2005030039A3 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage |
| 07/21/2005 | WO2005028657A3 Excretable reporter systems |
| 07/21/2005 | WO2005019460A3 Promoters for the expression of genes in tagetes |
| 07/21/2005 | WO2004038371A3 Ccr8 as modifier of branching morphogenesis and methods of use |
| 07/21/2005 | WO2004030617A3 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2002012541A3 Novel motor proteins and methods for their use |
| 07/21/2005 | US20050160500 Recombinant seeds for propagating drought and freeze resistant crops; early flowering |
| 07/21/2005 | US20050160498 Controlling flowering in plants via gene expression inhibition of cysteine proteases |
| 07/21/2005 | US20050160497 Protein which has an activity to produce raffinose from sucrose and galactinol |
| 07/21/2005 | US20050160492 Proteinase or methyltransferase inhibitors; enzyme inhibitors; treatment and prevention of pathogen infection; biological pest control |
| 07/21/2005 | US20050160489 Geranylgeranyl pyrophosphate synthases |
| 07/21/2005 | US20050160485 Mouse in which genome is modified |
| 07/21/2005 | US20050159901 Three-dimensional model; drug design |
| 07/21/2005 | US20050159384 Human RNase III and compositions and uses thereof |
| 07/21/2005 | US20050158861 Yeast transformation vector containing auxotrophic dominant gene yeast transfomant containing it and their preparation |
| 07/21/2005 | US20050158844 Methods for eliminating or reducing the expression of a genes in a filamentous fungal strains |
| 07/21/2005 | US20050158843 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 07/21/2005 | US20050158842 Microorganisms and assays for the identification of antibiotics |
| 07/21/2005 | US20050158839 comprises an amino acid sequence of a catalytic module having glucoamylase activity and an amino acid sequence of a carbohydrate-binding module; producing syrup or a fermentation product from granular starch comprising subjecting the raw starch to an alpha-amylase and a hybrid enzyme having glucoamylase |
| 07/21/2005 | US20050158838 Novel enterokinase cleavage sequences |
| 07/21/2005 | US20050158837 Immobilization of biocatalysts by template-directed silicate precipitation |
| 07/21/2005 | US20050158836 Transgenic microorganism comprising gene sequences coding alcohol dehydrogenase and pyruvate decarboxylase for use as bioreactor for fermentation of ethanol |
| 07/21/2005 | US20050158834 Using site directed mutagenesis in transgenic microorganism to generate single-stranded nicking enzyme |
| 07/21/2005 | US20050158833 Using enhanced green fluorescent protein as reporter molecule in studying cell lineages |
| 07/21/2005 | US20050158830 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158818 Recombinant hydrolase for use in the preparation of 7-amino-cephalosporanic acid; bioreactors |
| 07/21/2005 | US20050158816 Using yeast model comprising aequorin reporter as tool in screening compound toxicity; bioassay and drug screening |
| 07/21/2005 | US20050158811 Using ras palmitoyltransferase as tool in identifying modulators for treatment and prevention of liver disorders |
| 07/21/2005 | US20050158806 Population based assessments and means to rank the relative immunogenicity of proteins |
| 07/21/2005 | US20050158802 UbcH8 Ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an interferon alpha/beta induced Ubiquitin-like protein |
| 07/21/2005 | US20050158797 Mammalian CDP-diacylglycerol synthase |
| 07/21/2005 | US20050158789 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 07/21/2005 | US20050158776 Isolated human dehydrogenase proteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof |
| 07/21/2005 | US20050158774 Expression vector comprising plant seed coat promoter for use as tool in enhancement of transcription of heterologous gene expression sequences; bioreactors |
| 07/21/2005 | US20050158769 Using vector transformed cell as bioreactor vehicle for heterologous gene expression; directed protein evolution |
| 07/21/2005 | US20050158762 Novel 2,5-diketo-L-gluconic acid reductases and methods of use |
| 07/21/2005 | US20050158759 68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor |
| 07/21/2005 | US20050158757 Methods for the early diagnosis of ovarian cancer |
| 07/21/2005 | US20050158751 Using transformation vector to generate mutation in Drosophila Recombination Associated Protein (DRAP)gene for use in screening modulators to prevent and treat cancer and metabolic disorders |
| 07/21/2005 | US20050158749 Avermectin aglycon synthase genes |
| 07/21/2005 | US20050158748 Identification and functional characterization of a novel ribosomal S6 protein kinase |
| 07/21/2005 | US20050158732 Mixture comprising NH3-dependent NAD synthetase for use as model in identifying modulator for prevention an treatment of infection, respiratory and arthritic disorders |
| 07/21/2005 | US20050158730 Compositions and methods utilizing DNA polymerases |
| 07/21/2005 | US20050158716 Nucleic acid detection kits |
| 07/21/2005 | US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus |
| 07/21/2005 | US20050158705 Gene screening method using nuclear receptor |
| 07/21/2005 | US20050158332 MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158301 Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having six or more amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine; wound healing agent, cardiac repair, bone, promote cartilage repair or growth; antirestenosis |
| 07/21/2005 | US20050158300 Compositions and methods for modulating muscle cell and tissue contractility |
| 07/21/2005 | US20050158298 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; |
| 07/21/2005 | US20050158295 Modified plasminogen inhibitor type-1 and methods based thereon |
| 07/21/2005 | US20050158279 Administering a negative-strand RNA viral vector (sendai virus) containing FGF-1 or FGF-5 (fibroblast growth factors) as a foreign gene to animals; gene therapy |
| 07/21/2005 | US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production |
| 07/21/2005 | CA2552815A1 Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies |